(Carnesecca Arena, the home of St. John’s – Photo by Jason Schott)
Dribble for the Cure, the St. John’s Basketball programs’ premier charitable event of the year, is scheduled for Saturday, September 22. Registration opens at 10 a.m. and the welcome ceremony starts at 11:30 a.m.
St. John’s Basketball Head coaches Chris Mullin and Joe Tartamella will once again partner to raise funds for the Pediatric Cancer Research Foundation.
The eighth-annual event will serve as part of University Service Day.
St. John’s Dribble for the Cure attracts hundreds of participants annually and has raised more than $500,000 for pediatric cancer research since 2011. Participants dribble a basketball around campus alongside members of the men’s and women’s basketball teams, and are treated to entertainment, refreshments, games, face painting and much more.
This year, the Dribble for the Cure team that raises the most money for PCRF will receive the exclusive opportunity to participate in a high five tunnel on the court before a men’s basketball home game this season.
All proceeds directly support the PCRF Laboratory directed by Mitchell S. Cairo, M.D., at the Maria Fareri Children’s Hospital and New York Medical College. The work of Dr. Cairo, a world-renowned researcher, has contributed to dramatically increased survival rates of childhood cancers and blood disorders.
Founded by John Vallely, a former NBA player and a two-time national champion at UCLA, Dribble For The Cure was created as a way for college and university basketball programs to help raise money for children’s cancer research and bring dollars to local medical institutions for the care and treatment of children with cancer.
For more information or to register for the event visit, www.dribbleforthecure.com.
About the Pediatric Cancer Research Foundation (PCRF)
The Pediatric Cancer Research Foundation (PCRF) is an independent, nonprofit organization wholly dedicated to funding leading-edge pediatric cancer research nationwide. Since its founding in 1982, PCRF has raised more than $36 million toward the ultimate goal of ending pediatric cancer so children and their families can re-focus on the joys of childhood. This commitment has translated into immediate treatment for children with cancer by developing innovative treatment protocols, improving patients’ long-term quality of life, and supporting those scientists working on the precipice of important medical breakthroughs. For more information, visit www.PCRF-kids.org.